5-Amino-1MQ 50mg

Obesity can significantly affect one’s quality of life, limiting mobility and physical activity, and potentially leading to both physical and emotional challenges. Beyond these effects, it also increases the risk of serious diseases such as heart disease, diabetes, cancer, stroke, and non-alcoholic liver failure.

As weight increases, fat cells expand, resulting in excessive production of nicotinamide N-methyltransferase (NNMT), a cytosolic enzyme primarily active in fat tissue. NNMT slows down the metabolism of fat cells, disrupting the body’s metabolism and energy regulation, which can contribute to weight gain. The increased fat tissue also produces more hormones and pro-inflammatory signals, making fat loss more difficult without medical intervention.

A recent breakthrough offers hope for people dealing with severe obesity. The NNMT inhibitor 5-amino-1-methylquinoline (5-amino-1MQ) has been shown to reduce NNMT production, which regulates energy balance in fat cells. This mechanism may shrink white adipose tissue, significantly promoting weight loss without the need to restrict calorie intake. Beyond weight loss, 5-amino-1MQ offers numerous additional health benefits.

How 5-amino-1MQ Works

5-amino-1MQ is a small, selective, membrane-permeable molecule that inhibits NNMT, boosting levels of nicotinamide adenine dinucleotide (NAD+). NAD+ plays a crucial role in cellular reactions, and increased NAD+ enhances metabolic rate, leading to weight loss. Additionally, the activation of the SIRT1 gene, often referred to as “the longevity gene,” lowers the risk of diseases such as diabetes, cardiovascular issues, sleep apnea, and cancer.

Research on 5-amino-1MQ

1. Promotes Dramatic Weight Loss
   5-amino-1MQ stimulates brown adipose tissue (BAT), a key player in fat metabolism and thermogenesis, which burns stored fat for heat. Through a process called browning, white fat cells are converted into beige fat cells, increasing their fat-burning capacity. This helps reduce overall fat stores and promotes weight loss without dietary changes. In clinical studies, 5-amino-1MQ has shown significant weight loss effects without adverse side effects.

In animal studies:

• 5-amino-1MQ reduced body weight and fat mass in mice on a high-fat diet, enhancing fat cell metabolism and reducing adipocyte size.
• It protected against fat accumulation by increasing cellular energy expenditure.

1. Lowers Cholesterol Levels
   By increasing NAD+ and activating SIRT1, 5-amino-1MQ helps break down cholesterol, preventing its buildup in the bloodstream. This reduces the risk of heart disease, kidney disease, and hypertension. Research shows that 5-amino-1MQ lowered cholesterol levels in mice and suppressed cholesterol synthesis.
2. Improves Blood Sugar Levels
   5-amino-1MQ enhances insulin sensitivity, allowing cells to more efficiently use sugar from the bloodstream. This helps lower blood sugar levels, benefiting people with type II diabetes. Animal studies have shown that 5-amino-1MQ reduced blood sugar levels without adverse effects.
3. Fights Inflammation
   5-amino-1MQ acts as an anti-inflammatory agent by reducing molecules that promote inflammation. Elevated NNMT levels are linked with inflammatory conditions, and inhibiting NNMT helps reduce this inflammation, potentially alleviating chronic conditions.
4. Combats Cancer
   5-amino-1MQ disrupts the energy supply to cancer cells by interfering with glycolysis, which cancer cells rely on for rapid growth. This reduction in glucose availability hampers cancer cell growth and enhances the effectiveness of other cancer treatments. NNMT is implicated in various cancers, and inhibiting its production may slow tumor growth and improve survival rates.
5. Enhances Aged Muscle Regeneration
   5-amino-1MQ rejuvenates satellite cells, which are responsible for muscle repair and growth. As we age, these cells become less effective, leading to muscle loss. By boosting satellite cell activity, 5-amino-1MQ promotes muscle regeneration, helping to combat muscle loss and weakness associated with aging.

In aging studies:

• In aged mice, 5-amino-1MQ improved muscle function and regeneration, suggesting potential for treating muscle-wasting disorders and improving overall muscle health.

5-amino-1MQ is emerging as a powerful tool for combating obesity, metabolic disorders, and aging, offering significant health benefits beyond just weight loss.

References

1. Neelakantan H, Vance V, Wetzel MD, et al. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice. BiochemPharmacol. 2018;147:141–152. doi:10.1016/j.bcp.2017.11.007
2. Kraus D, et al. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014; 508:258–262.
3. Kannt A, et al. Association of nicotinamide-N-methyltransferase mRNA expression in humanadipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulinresistance. Diabetologia. 2015; doi: 10.1007/s00125-014-
4. Liu M, et al. Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese.J ClinEndocrinolMetab. 2015; 100:3112–3117.
5. Pissios P. Nicotinamide N-Methyltransferase: More Than a Vitamin B3 Clearance Enzyme. Trends EndocrinolMetab. 2017;28(5):340–353.
6. Neelakantan H, Wang HY, Vance V, Hommel JD, McHardy SF, Watowich SJ. Structure-Activity Relationship for Small Molecule Inhibitors of Nicotinamide N-Methyltransferase. J Med Chem. 2017;60(12):5015–5028.
7. Kim, Y. B., Peroni, O. D., Aschenbach, W. G., Minokoshi, Y., Kotani, K., Zisman, A., Kahn, C. R., Goodyear, L. J., & Kahn, B. B. (2005). Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism. Molecular and cellular biology, 25(21), 9713–9723. https://doi.org/10.1128/MCB.25.21.9713-9723.2005.
8. Carvalho, E., Kotani, K., Peroni, O. D., & Kahn, B. B. (2005). Adipose-specific overexpression of GLUT4 reverses insulin resistance and diabetes in mice lacking GLUT4 selectively in muscle. American journal of physiology. Endocrinology and metabolism, 289(4), E551–E561. https://doi.org/10.1152/ajpendo.00116.2005.
9. Ye, M. Li, T. Hou, T. Gao, W.-g. Zhu, Y. Yang. Sirtuins in glucose and lipid metabolism. Oncotarget, 8 (1) (2016), pp. 1845-1859.
10. Yaguchi, K. Togawa, M. Moritani, and M. Itakura, “Identification of candidate genes in the type 2 diabetes modifier locus using expression QTL,” Genomics, vol. 85, no. 5, pp. 591–599, 2005.
11. Kannt, A. Pfenninger, L. Teichert et al., “Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance,” Diabetologia, vol. 58, no. 4, pp. 799–808, 2015.
12. Kraus, Q. Yang, D. Kong et al., “Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity,” Nature, vol. 508, no. 7495, pp. 258–262, 2014.
13. Hong, J. M. Moreno-Navarrete, X. Wei et al., “NicotinamideN -methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization,” Nature medicine, vol. 21, no. 8, pp. 887–894, 2015.
14. H. Li, Y. H. Wang, X. J. Zhu, Q. Zhou, Z. H. Xie, and T. F. Yao, “Metabolomics study on the association between nicotinamide N-methyltransferase gene polymorphisms and type 2 diabetes,” International Journal of Diabetes in Developing Countries, vol. 38, pp. 409–416, 2018.
15. Moraes-Vieira, P. M., Saghatelian, A., & Kahn, B. B. (2016). GLUT4 Expression in Adipocytes Regulates De Novo Lipogenesis and Levels of a Novel Class of Lipids With Antidiabetic and Anti-inflammatory Effects. Diabetes, 65(7), 1808–1815. https://doi.org/10.2337/db16-0221.
16. Kim HC, et al. Expression and functional significance of nicotinamide N-methyl transferase inskeletal muscles of patients with chronic obstructive pulmonary disease. Am J RespirCrit CareMed. 2010; 181:797–805.
17. Savarimuthu Francis SM, et al. Genes and gene ontologies common to airflow obstruction andemphysema in the lungs of patients with COPD. PloS One. 2011; 6:e17442.
18. Sternak M, et al. Nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA) in experimental hepatitis induced by concanavalin A in the mouse. Pharmacol Rep PR. 2010;62:483–493.
19. Fedorowicz A, et al. Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension. Respir Res. 2016; 17:108.
20. Jakubowski A, et al. 1-Methylnicotinamide protects against liver injury induced by concanavalin Avia a prostacyclin-dependent mechanism: A possible involvement of IL-4 and TNF-α. IntImmunopharmacol. 2016; 31:98–104.
21. Markert JM, et al. Differential gene expression profiling in human brain tumors. Physiol Genomics. 2001;5:21–33.
22. Xu J, et al. Enhanced expression of nicotinamide N-methyltransferase in human papillary thyroid carcinoma cells. J ClinEndocrinolMetab. 2003;88:4990–4996.
23. Yao M, et al. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma. J Pathol. 2005;205:377–387.